Hubei Jumpcan Pharmaceutical Co.,Ltd.’s Net Profit Rose 24.7% in First Half of 2021
Hubei Jumpcan Pharmaceutical Co.,Ltd. (湖北济川药业股份有限公司) (600566.SH) reported a net profit of 853.8 million yuan in the first half of 2021, up 24.7% year-on-year.
Meanwhile, the company posted 3.7 billion yuan in revenue, up 24.8% year-on-year.
At the end of the reporting period, it had 11.1 billion yuan in total assets and 2.9 billion yuan in total liabilities, with a liability-to-asset ratio of 26.1%.
This article was automatically produced by Caixin Automation on Aug. 26, 2021.
Download our app to receive breaking news alerts and read the news on the go.
Follow the Chinese markets in real time with Caixin Global’s new stock database.
- MOST POPULAR